400 mg of L-Arginine: What That Amount Actually Means for Blood Flow
MemoHoney provides about 400 mg of total L-Arginine (200 mg base + 200 mg AKG). Circulation research typically uses 3,000–6,000 mg per day, and oral arginine loses a large share to first-pass metabolism. At 400 mg the contribution to nitric oxide is real but small — think gentle direction, not a measurable vasodilatory dose.
- ~400 mg combined
- Research: 3–6 g/day
- Heavy first-pass loss
- Paired with citrulline for efficiency
What arginine does in the body
L-Arginine is a semi-essential amino acid and the direct substrate for nitric oxide synthase. Endothelial cells convert it into nitric oxide, which relaxes the smooth muscle of vessel walls. That is the whole basis for arginine's presence in circulation formulas, and the pathway is not controversial — it earned a Nobel Prize in 1998.
What is debated is whether adding oral arginine changes anything, because the body already makes and eats plenty. A typical diet supplies 4–6 g a day. Supplementation only matters when it raises plasma arginine enough to shift enzyme activity — and that is a dose question.
The first-pass problem
Roughly half or more of swallowed arginine is metabolised by the gut wall and liver before it reaches general circulation, largely by the enzyme arginase. Studies that show blood-flow effects use 3 g or more precisely to overwhelm that loss. At 400 mg, perhaps 150–200 mg reaches systemic circulation — a small addition against a dietary background of several grams.
This is why serious formulators pair arginine with citrulline. Citrulline is absorbed intact, skips arginase, and is turned into arginine in the kidneys. MemoHoney does include both, which is the correct design; the doses of each are simply modest.
What the research at higher doses shows
At 3–6 g per day, trials report improvements in flow-mediated dilation in some populations, modest blood-pressure reductions, and better exercise tolerance in people with impaired circulation. Effects in healthy adults are smaller and inconsistent. The cognition-specific literature is thinner still and mostly preclinical. Nothing at the 400 mg level has been tested in a published human trial we could find.
Reading 400 mg honestly
Nitric oxide production is dose-responsive, not a switch, so a sub-gram dose is not zero. Taken daily, alongside the citrulline, it nudges the substrate pool in the right direction. That is a fair description; "clinically dosed" would not be. If you want the research-level effect, you need a research-level dose from a powder — and you also inherit the research-level interaction risk with blood pressure and nitrate medication.
What this means for MemoHoney
MemoHoney's arginine is correctly formulated (two forms, paired with citrulline) and honestly labelled — but sub-gram. Expect gradual support over weeks, not the acute blood-flow effect seen in gram-dose trials.
| Ingredient | Per capsule | Research / RDA range |
|---|---|---|
| Niacin (Vitamin B3) | 7.5 mg NE | 14–16 mg NE (RDA) |
| Calcium | 18 mg | 1,000–1,200 mg (RDA) |
| L-Arginine (base) | 200 mg | 3,000–6,000 mg |
| L-Arginine AKG 2:1 | 200 mg | 3,000–6,000 mg |
| L-Citrulline HCl | 100 mg | 3,000–8,000 mg |
| L-Citrulline Malate | 100 mg | 3,000–8,000 mg |
| Beta-Alanine | 40 mg | 2,000–6,000 mg |
Every MemoHoney amount is printed on the label — no proprietary blend. Full analysis on the ingredients page; mechanism on how it works.
Key takeaways
- 400 mg is roughly 13% of the lowest common research dose.
- Pairing with citrulline is the right design choice.
- Direction of effect is real; magnitude at this dose is small and untested.
FAQ
For healthy adults, yes — it is below a typical dietary intake. People on blood pressure or nitrate medication should still check with a doctor because of the pathway.
For circulation, research suggests yes up to about 6 g, but at those doses side effects (GI upset, blood pressure changes) and interactions become meaningful.
Base arginine and arginine-AKG both deliver arginine. AKG is claimed to aid uptake; evidence for that is weak. Treat both as the same ingredient.